Literature DB >> 10899025

Immunity to Listeria infection.

B T Edelson1, E R Unanue.   

Abstract

Infection with Listeria monocytogenes is a well studied model for understanding host resistance to intracellular bacteria. Recent advances in the study of Listeria have carefully quantitated the response of CD8(+) T cells to infection and analyzed the effector functions of these cells in vivo. A surprising role for antibody in mediating resistance to Listeria has also recently emerged, providing new insight into the mechanisms of host defense.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10899025     DOI: 10.1016/s0952-7915(00)00112-6

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  49 in total

1.  Intranasal vaccination with the recombinant Listeria monocytogenes ΔactA prfA* mutant elicits robust systemic and pulmonary cellular responses and secretory mucosal IgA.

Authors:  Jin Qiu; Lin Yan; Jianbo Chen; Crystal Y Chen; Ling Shen; Norman L Letvin; Barton F Haynes; Nancy Freitag; Lijun Rong; James T Frencher; Dan Huang; Xunming Wang; Zheng W Chen
Journal:  Clin Vaccine Immunol       Date:  2011-01-26

2.  Machine learning analysis of the relationship between changes in immunological parameters and changes in resistance to Listeria monocytogenes: a new approach for risk assessment and systems immunology.

Authors:  Zhifa Liu; Changhe Yuan; Stephen B Pruett
Journal:  Toxicol Sci       Date:  2012-06-13       Impact factor: 4.849

Review 3.  Listeria endocarditis in a patient with psoriatic arthritis on infliximab: are biologic agents as treatment for inflammatory arthritis increasing the incidence of Listeria infections?

Authors:  Theodoros Kelesidis; Amandeep Salhotra; Jorge Fleisher; Daniel Z Uslan
Journal:  J Infect       Date:  2010-02-20       Impact factor: 6.072

4.  Indoleamine 2,3-dioxygenase-expressing dendritic cells form suppurative granulomas following Listeria monocytogenes infection.

Authors:  Alexey Popov; Zeinab Abdullah; Claudia Wickenhauser; Tomo Saric; Julia Driesen; Franz-Georg Hanisch; Eugen Domann; Emma Lloyd Raven; Oliver Dehus; Corinna Hermann; Daniela Eggle; Svenja Debey; Trinad Chakraborty; Martin Krönke; Olaf Utermöhlen; Joachim L Schultze
Journal:  J Clin Invest       Date:  2006-11-16       Impact factor: 14.808

5.  The adjuvant activity of CpG DNA requires T-bet expression in dendritic cells.

Authors:  Geanncarlo Lugo-Villarino; Shu-Ichi Ito; Dennis M Klinman; Laurie H Glimcher
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-31       Impact factor: 11.205

Review 6.  Antigen presentation: lysoyme, autoimmune diabetes, and Listeria--what do they have in common?

Authors:  Emil Unanue; Craig Byersdorfer; Javier Carrero; Matteo Levisetti; Scott Lovitch; Zheng Pu; Anish Suri
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

7.  Essential role of CCL2 in clustering of splenic ERTR-9+ macrophages during infection of BALB/c mice by Listeria monocytogenes.

Authors:  Jadwiga Jablonska; Kurt E Dittmar; Tanja Kleinke; Jan Buer; Siegfried Weiss
Journal:  Infect Immun       Date:  2006-10-30       Impact factor: 3.441

8.  InlA and InlC2 of Listeria monocytogenes serotype 4b are two internalin proteins eliciting humoral immune responses common to listerial infection of various host species.

Authors:  Wei Ling Yu; Hanhong Dan; Min Lin
Journal:  Curr Microbiol       Date:  2008-01-29       Impact factor: 2.188

9.  The bradykinin B2 receptor in the early immune response against Listeria infection.

Authors:  Wendy E Kaman; Arthur F W M Wolterink; Michael Bader; Linda C L Boele; Desiree van der Kleij
Journal:  Med Microbiol Immunol       Date:  2008-09-23       Impact factor: 3.402

10.  IL-23 receptor regulates unconventional IL-17-producing T cells that control bacterial infections.

Authors:  Lorena Riol-Blanco; Vanja Lazarevic; Amit Awasthi; Meike Mitsdoerffer; Brian S Wilson; Andy Croxford; Ari Waisman; Vijay K Kuchroo; Laurie H Glimcher; Mohamed Oukka
Journal:  J Immunol       Date:  2010-01-18       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.